Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012 (2012), Article ID 615835, 9 pages
http://dx.doi.org/10.1155/2012/615835
Clinical Study

Links between Metabolic Syndrome and Cardiovascular Autonomic Dysfunction

1Unit of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantations (D.E.T.O.), University of Bari “A. Moro”, 70124 Bari, Italy
2Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, 66030 Santa Maria Imbaro, Chieti, Italy
3Unit of Biostatistics, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Foggia, Italy

Received 8 November 2011; Accepted 13 December 2011

Academic Editor: Nicola Montano

Copyright © 2012 G. Garruti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Vinik and T. Erbas, “Recognizing and treating diabetic autonomic neuropathy,” Cleveland Clinic Journal of Medicine, vol. 68, no. 11, pp. 928–944, 2001. View at Google Scholar · View at Scopus
  2. A. Langer, M. R. Freeman, R. G. Josse, G. Steiner, and P. W. Armstrong, “Detection of silent myocardial ischemia in diabetes mellitus,” American Journal of Cardiology, vol. 67, no. 13, pp. 1073–1078, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Low, L. M. Benrud-Larson, D. M. Sletten et al., “Autonomic symptoms and diabetic neuropathy: a population-based study,” Diabetes Care, vol. 27, no. 12, pp. 2942–2947, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. S. Church, A. M. Thompson, P. T. Katzmarzyk et al., “Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men,” Diabetes Care, vol. 32, no. 7, pp. 1289–1294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. International Diabetes Federation Launches First Global Guideline for Menagement of Type 2 Diabetes Asianet, 2005.
  7. P. Zimmet, D. Magliano, Y. Matsuzawa, G. Alberti, and J. Shaw, “The metabolic syndrome: a global public health problem and a new definition,” Journal of atherosclerosis and thrombosis., vol. 12, no. 6, pp. 295–300, 2005. View at Google Scholar · View at Scopus
  8. G. Vespasiani, M. Bruni, I. Meloncelli et al., “Validation of a computerised measurement system for guided routine evaluation of cardiovascular autonomic neuropathy,” Computer Methods and Programs in Biomedicine, vol. 51, no. 3, pp. 211–216, 1996. View at Publisher · View at Google Scholar
  9. P. Portincasa, A. Moschetta, M. Berardino et al., “Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in β-thalassemia major adults,” World Journal of Gastroenterology, vol. 10, no. 16, pp. 2383–2390, 2004. View at Google Scholar
  10. C. Cardone, F. Bellavere, M. Ferri, and D. Fedele, “Autonomic mechanisms in the heart rate response to coughing,” Clinical Science, vol. 72, no. 1, pp. 55–60, 1987. View at Google Scholar · View at Scopus
  11. C. Cardone, P. Paiusco, G. Marchetti, F. Burelli, M. Feruglio, and D. Fedele, “Cough test to assess cardiovascular autonomic reflexes in diabetes,” Diabetes Care, vol. 13, no. 7, pp. 719–724, 1990. View at Google Scholar · View at Scopus
  12. R. Freeman, L. Landsberg, and J. Young, “The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo- dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial,” Neurology, vol. 53, no. 9, pp. 2151–2157, 1999. View at Google Scholar · View at Scopus
  13. P. A. Low, J. C. Walsh, C. Y. Huang, and J. G. McLeod, “The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study,” Brain, vol. 98, no. 3, pp. 341–356, 1975. View at Google Scholar · View at Scopus
  14. O. Appenzeller, “Report on the 20th International Congress of Neurovegetative (Autonomic) Research, September 1990, Tokyo, Japan,” Clinical Autonomic Research, vol. 1, no. 1, pp. 75–76, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Ravits, “AAEM minimonograph 48: autonomic nervous system testing,” Muscle and Nerve, vol. 20, no. 8, pp. 919–937, 1997. View at Publisher · View at Google Scholar
  16. D. Ziegler, F. A. Gries, H. Muhlen et al., “Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers,” Diabete et Metabolisme, vol. 19, no. 1 BIS, pp. 143–151, 1993. View at Google Scholar
  17. A. I. Vinik and D. Ziegler, “Diabetic cardiovascular autonomic neuropathy,” Circulation, vol. 115, no. 3, pp. 387–397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Freeman, “Assessment of cardiovascular autonomic function,” Clinical Neurophysiology, vol. 117, no. 4, pp. 716–730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gottsäter, M. Kangro, and G. Sundkvist, “Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction? Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects,” Diabetic Medicine, vol. 21, pp. 1304–1309, 2004. View at Google Scholar
  20. J. Stephenson and J. H. Fuller, “Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study,” Diabetologia, vol. 37, no. 3, pp. 278–285, 1994. View at Google Scholar · View at Scopus
  21. H. A. W. Neil, A. V. Thompson, S. John, S. T. McCarthy, and J. I. Mann, “Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population,” Diabetic Medicine, vol. 6, no. 1, pp. 20–24, 1989. View at Google Scholar · View at Scopus
  22. A. Gottsäter, M. Ahmed, P. Fernlund, and G. Sundkvist, “Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia,” Diabetic Medicine, vol. 16, no. 1, pp. 49–54, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Szelag, M. Wroblewski, J. Castenfors et al., “Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes,” Diabetes Care, vol. 22, no. 11, pp. 1907–1908, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Takayama, H. Sakura, K. Katsumori, T. Wasada, and Y. Iwamoto, “A possible involvement of parasympathetic neuropathy on insulin resistance in patients with type 2 diabeties,” Diabetes Care, vol. 24, no. 5, pp. 968–969, 2001. View at Google Scholar · View at Scopus
  25. DCCT Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus,” New England Journal of Medicine, vol. 329, no. 14, pp. 977–986, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. A. J. Burger, L. A. Weinrauch, J. A. D'Elia, and D. Aronson, “Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy,” American Journal of Cardiology, vol. 84, no. 6, pp. 687–691, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Gaede, P. Vedel, H. H. Parving, and O. Pedersen, “Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study,” The Lancet, vol. 353, no. 9153, pp. 617–622, 1999. View at Publisher · View at Google Scholar
  28. J. E. Shaw, P. Z. Zimmet, F. Z. Gries, and D. Ziegler, “Epidemiology of diabetic neuropathy,” in Textbook of Diabetic Neuropathy, F. A. Griesw, N. E. Cameron, P. A. Low, and D. Ziegler, Eds., pp. 64–82, Thieme Medical Publishers, New York, NY, USA, 2003. View at Google Scholar
  29. A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003. View at Publisher · View at Google Scholar
  30. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus